Analystreport

Trillium Therapeutics Inc. (NASDAQ: TRIL) was downgraded by analysts at Bloom Burton from a "buy" rating to an "accumulate" rating.

Trillium Therapeutics Inc. - Common Shares  (TRIL) 
Last trillium therapeutics inc. - common shares earnings: 5/13 07:00 am Check Earnings Report